mRNA Vaccines, Mask Mandates, and the COVID-19 Response (Paul Offit)
b"
As a member of the FDA Vaccine Advisory Committee and a former member of the Advisory Committee for Immunization Practices to the CDC, Dr. Paul Offit has been in the room for the creation of policies that have affected hundreds of millions of people.
Four years after the outbreak of COVID-19, he reflects on our response to the pandemic: what went well and what didn't.
Shermer and Offit discuss: mRNA vaccines \\u2022 loss of trust in medical and scientific institutions \\u2022 overall assessment of what went right and wrong \\u2022 mandates vs. recommendations \\u2022 economic costs \\u2022 lab leak hypothesis vs. zoonomic hypothesis \\u2022 debating anti-vaxxers \\u2022 treatments \\u2022 high risk vs. low risk groups
Paul Offit is the Director of the Vaccine Education Center at the Children\\u2019s Hospital of Philadelphia and Professor of Vaccinology and Professor of Pediatrics at the University of Pennsylvania.\\xa0Offit has published more than 170 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the co-inventor of the rotavirus vaccine, RotaTeq, recommended for universal use in infants by the CDC and WHO.
"